Last updated: November 10, 2025
Sponsor: Johns Hopkins University
Overall Status: Active - Enrolling
Phase
N/A
Condition
Blood Clots
Cardiac Ischemia
Stroke
Treatment
high intensity dysphagia therapy
Clinical Study ID
NCT05970406
IRB00335053
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ages 18-99
Ischemic Stroke
Identified to have acute dysphagia s/p ischemic stroke
Able to follow 1-step commands for swallowing directions
Exclusion
Exclusion Criteria:
Younger than 18, older than 100
Hemorrhagic Stroke, Subarachnoid hemorrhage, subdural hematoma, epidural hematoma
h/o dysphagia
Advanced progressive neurological disease
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: high intensity dysphagia therapy
Phase:
Study Start date:
November 30, 2023
Estimated Completion Date:
November 30, 2027
Study Description
Connect with a study center
Johns Hopkins Bayview Medical Center
Baltimore, Maryland 21224
United StatesSite Not Available
Johns Hopkins Bayview Medical Center
Baltimore 4347778, Maryland 4361885 21224
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.